Nyxoah SA $NYXH Shares Sold by Vestal Point Capital LP

Key Points

• Vestal Point Capital LP has reduced its stake in Nyxoah SA by 20.7%, selling 605,262 shares and owning a total of 2,318,954 shares at the end of the first quarter.
• Nyxoah reported a loss of ($0.63) EPS for the latest quarter, slightly missing analysts' expectations, while revenues exceeded estimates at $1.58 million.
• The stock of Nyxoah opened at $6.24, with a market cap of approximately $212.53 million and a 52-week performance ranging between $5.55 and $11.87.

Vestal Point Capital LP lessened its holdings in shares of Nyxoah SA (NASDAQ:NYXH - Free Report) by 20.7% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,318,954 shares of the company's stock after selling 605,262 shares during the quarter. Vestal Point Capital LP owned 6.81% of Nyxoah worth $16,186,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in NYXH. Geode Capital Management LLC grew its holdings in Nyxoah by 19.4% during the 4th quarter. Geode Capital Management LLC now owns 17,100 shares of the company's stock worth $137,000 after acquiring an additional 2,774 shares in the last quarter. Kovack Advisors Inc. lifted its position in shares of Nyxoah by 16.5% during the first quarter. Kovack Advisors Inc. now owns 23,295 shares of the company's stock worth $163,000 after purchasing an additional 3,295 shares during the last quarter. Ameriprise Financial Inc. acquired a new position in Nyxoah in the fourth quarter worth about $135,000. Finally, Renaissance Technologies LLC bought a new stake in Nyxoah in the fourth quarter valued at about $187,000.

Nyxoah Stock Performance

Shares of NYXH traded up $0.23 during mid-day trading on Friday, hitting $5.93. The stock had a trading volume of 32,144 shares, compared to its average volume of 160,054. Nyxoah SA has a fifty-two week low of $5.55 and a fifty-two week high of $11.87. The company has a quick ratio of 2.38, a current ratio of 2.63 and a debt-to-equity ratio of 0.29. The company has a market cap of $201.98 million, a PE ratio of -2.58 and a beta of 1.60. The company's fifty day simple moving average is $7.12 and its two-hundred day simple moving average is $7.58.

Nyxoah (NASDAQ:NYXH - Get Free Report) last announced its quarterly earnings data on Monday, August 18th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.62) by ($0.01). The firm had revenue of $1.58 million for the quarter, compared to the consensus estimate of $1.33 million. Nyxoah had a negative return on equity of 79.18% and a negative net margin of 1,541.84%. On average, equities analysts expect that Nyxoah SA will post -1.91 earnings per share for the current year.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.